Our nation pays - by far - the highest prices in the world for prescription drugs. As a result of these prices, nearly one in five Americans cannot afford to fill their prescriptions. At what point do we say our tax system, our publicly funded research and our patent system are not serving the public interest?
Employers are finding it necessary to vigilantly watch prescription drug prices. They are striving to keep costs controlled by trying new approaches like using five or more tiers for cost sharing, where the highest tier is for the highest-priced drugs--usually specialty drugs. Moving forward, employers will continue exploring unique cost-saving measures like referenced-based pricing.